These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7645249)

  • 21. Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity.
    Yu SF; Benton P; Bovee M; Sessions J; Lloyd RE
    J Virol; 1995 Jan; 69(1):247-52. PubMed ID: 7983716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple eIF4GI-specific protease activities present in uninfected and poliovirus-infected cells.
    Zamora M; Marissen WE; Lloyd RE
    J Virol; 2002 Jan; 76(1):165-77. PubMed ID: 11739682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cleavage of p220 by purified poliovirus 2A(pro) in cell-free systems: effects on translation of capped and uncapped mRNAs.
    Novoa I; Martínez-Abarca F; Fortes P; Ortín J; Carrasco L
    Biochemistry; 1997 Jun; 36(25):7802-9. PubMed ID: 9201923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of poliovirus proteinase 3Cpro-related proteolysis by the genome-linked protein VPg and its precursor 3AB.
    Molla A; Harris KS; Paul AV; Shin SH; Mugavero J; Wimmer E
    J Biol Chem; 1994 Oct; 269(43):27015-20. PubMed ID: 7929442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases.
    de Breyne S; Bonderoff JM; Chumakov KM; Lloyd RE; Hellen CU
    Virology; 2008 Aug; 378(1):118-22. PubMed ID: 18572216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase.
    Harris KS; Reddigari SR; Nicklin MJ; Hämmerle T; Wimmer E
    J Virol; 1992 Dec; 66(12):7481-9. PubMed ID: 1331532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cleavage of synthetic peptides by purified poliovirus 3C proteinase.
    Pallai PV; Burkhardt F; Skoog M; Schreiner K; Bax P; Cohen KA; Hansen G; Palladino DE; Harris KS; Nicklin MJ
    J Biol Chem; 1989 Jun; 264(17):9738-41. PubMed ID: 2542331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliovirus infection results in structural alteration of a microtubule-associated protein.
    Joachims M; Etchison D
    J Virol; 1992 Oct; 66(10):5797-804. PubMed ID: 1326643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poliovirus protease does not mediate cleavage of the 220,000-Da component of the cap binding protein complex.
    Lloyd RE; Etchison D; Ehrenfeld E
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2723-7. PubMed ID: 2986132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A.
    Lloyd RE; Toyoda H; Etchison D; Wimmer E; Ehrenfeld E
    Virology; 1986 Apr; 150(1):299-303. PubMed ID: 3006342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mengo virus 3C proteinase: recombinant expression, intergenus substrate cleavage and localization in vivo.
    Hall DJ; Palmenberg AC
    Virus Genes; 1996; 13(2):99-110. PubMed ID: 8972564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the susceptibility of the 3C proteases of hepatitis A virus and poliovirus to degradation by the ubiquitin-mediated proteolytic system.
    Gladding RL; Haas AL; Gronros DL; Lawson TG
    Biochem Biophys Res Commun; 1997 Sep; 238(1):119-25. PubMed ID: 9299463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the cleavage site and determinants required for poliovirus 3CPro-catalyzed cleavage of human TATA-binding transcription factor TBP.
    Das S; Dasgupta A
    J Virol; 1993 Jun; 67(6):3326-31. PubMed ID: 8388502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity.
    Weidman MK; Yalamanchili P; Ng B; Tsai W; Dasgupta A
    Virology; 2001 Dec; 291(2):260-71. PubMed ID: 11878895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
    Ansardi DC; Morrow CD
    J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of poliovirus 2A(pro) on vaccinia virus gene expression.
    Feduchi E; Aldabe R; Novoa I; Carrasco L
    Eur J Biochem; 1995 Dec; 234(3):849-54. PubMed ID: 8575444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct cleavage of elF4G by poliovirus 2A protease is inefficient in vitro.
    Bovee ML; Lamphear BJ; Rhoads RE; Lloyd RE
    Virology; 1998 Jun; 245(2):241-9. PubMed ID: 9636363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of poliovirus polypeptide 3CDpro with the 5' and 3' termini of the poliovirus genome. Identification of viral and cellular cofactors needed for efficient binding.
    Harris KS; Xiang W; Alexander L; Lane WS; Paul AV; Wimmer E
    J Biol Chem; 1994 Oct; 269(43):27004-14. PubMed ID: 7929441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of putative active site residues of the poliovirus 3C protease.
    Kean KM; Teterina NL; Marc D; Girard M
    Virology; 1991 Apr; 181(2):609-19. PubMed ID: 1849679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular redistribution of truncated La protein produced by poliovirus 3Cpro-mediated cleavage.
    Shiroki K; Isoyama T; Kuge S; Ishii T; Ohmi S; Hata S; Suzuki K; Takasaki Y; Nomoto A
    J Virol; 1999 Mar; 73(3):2193-200. PubMed ID: 9971802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.